Who Paid My Doc
Endometrin
Drug Reproductive Health
NDC 55566-6500-3
General payments
$42,444
Research payments
$5,653
Through program year 2025, $42,444 in general payments and $5,653 in research payments were reported against Endometrin (Reproductive Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,591 | 29 |
| 2024 | General | $2,031 | 36 |
| 2023 | General | $2,778 | 40 |
| 2022 | General | $1,586 | 68 |
| 2021 | General | $18,509 | 134 |
| 2020 | General | $5,236 | 68 |
| 2019 | General | $10,713 | 338 |
| 2019 | Research | $5,653 | 1 |
Breakdown
The top 5 of 21 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 8 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
713 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.